Elevated levels of the inflammatory cytokine interleukin-6 (IL-6) occur in a number of CNS disorders. However, little is known about how this condition affects CNS neuronal function. Transgenic mice that express elevated levels of IL-6 in the CNS show cognitive changes, increased propensity for hippocampal seizures and reduced number of inhibitory interneurons, suggesting that elevated levels of IL-6 can cause neuroadaptive changes that alter hippocampal function. To identify these neuroadaptive changes, we measured the levels of protein expression using Western blot analysis and synaptic function using field potential recordings in hippocampus from IL-6 transgenic mice (IL-6 tg) and their non-transgenic (nontg) littermates. Western blot analysis showed enhanced levels of the GFAP and STAT3 in the IL-6 tg hippocampus compared with the non-tg hippocampus, but no difference for several other proteins. Field potential recordings of synaptic transmission at the Schaffer collateral to CA1 synapse showed enhanced dendritic excitatory postsynaptic potentials and somatic population spikes in the CA1 region of hippocampal slices from IL-6 tg mice compared with slices from non-tg littermate controls. No differences were observed for several forms of short-term and long-term synaptic plasticity between hippocampal slices from IL-6 tg and non-tg mice. These results demonstrate that elevated levels of IL-6 can alter mechanisms involved in the excitability of hippocampal neurons and synapses, an effect consistent with recent evidence indicating that elevated production of IL-6 plays an important role in conditions associated with seizure activity and in other impairments observed in CNS disorders with a neuroinflammatory component.
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Introduction
Interleukin-6 (IL-6) is a pro-inflammatory cytokine that plays a crucial role in the host defense response to infection and trauma (Akira et al., 1990; Heinrich et al., 1990; Hirano, 1992) . IL-6 is also an essential mediator of neuroimmune responses within the central nervous system (CNS), where it can play a neurotrophic, neuroprotective or neurotoxic role depending on conditions (Gadient and Otten, 1997; Gruol and Nelson, 1997; Spooren et al., 2011) . The expression of elevated levels of IL-6 and other cytokines in the CNS is thought to be a contributing factor to the neuropathological and pathophysiological features associated with several CNS disorders such as AIDS dementia complex (Gallo et al., 1989; Tyor et al., 1992 ), Alzheimer's disease (Bauer et al., 1991) , multiple sclerosis (Maimone et al., 1991) , epilepsy (Li et al., 2011), depression (Miller and O'Callaghan, 2005 ) and Parkinson's disease (Mogi et al., 1994) . Studies in experimental animals support a role for IL-6 in CNS disease states including seizure activity (Campbell et al., 1993; Kirkman et al., 2010) , infection (Sauder and de la Torre, 1999), chronic variable stress (Tagliari et al., 2011 ), Alzheimer's disease (Ruan et al., 2009; Tehranian et al., 2001 ) and other CNS disorders (Spooren et al., 2011; Wu and Lin, 2008) .
In addition to a role in CNS disease states, emerging evidence implicates a role for IL-6 in the normal regulation of physiological functions of CNS neurons. CNS neurons have been shown to express functional receptors for IL-6 (Gadient and Otten, 1994 ) and IL-6 production can be induced by neuronal activity (Sallmann et al., 2000) . Basal levels of IL-6 in the CNS are low under normal conditions, but localized increases in IL-6 mRNA levels are produced by intense synaptic or neuronal activity such as occurs experimentally during induction of hippocampal long-term potentiation (LTP) (Balschun et al., 2004; Jankowsky et al., 2000; Jankowsky and Patterson, 1999) . LTP is a form of synaptic plasticity that is thought to be a cellular mechanism underlying learning and memory (Bliss and Collingridge, 1993) . Studies show that the endogenous IL-6
